Insulin resistance often develops years before diabetes, heart disease, or dementia are diagnosed. During this silent phase, metabolic dysfunction damages blood vessels, the brain, and cellular aging pathways. Understanding insulin resistance early allows for targeted intervention that can meaningfully reduce cardiovascular risk, cognitive decline, and accelerated biological aging.

Low dose lithium may be a useful tool in the treatment and prevention of memory loss and alzheimer's disease. Well below the dosages used to treat psychiatric disorders, low dose lithium may provide symptomatic relief and may forestall or prevent the development of age related memory loss and dementia.